J.P. Morgan Keeps Their Buy Rating on AstraZeneca (AZN)
In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...